| 1 | Cancer | 2.56% | |
| 2 | Methotrexate | 2.56% | |
| 3 | Urothelial | 2.56% | |
| 4 | Study | 2.56% | |
| 5 | Reviewed | 2.56% | |
| 6 | Sugar | 2.56% | |
| 7 | Natural | 2.56% | |
| 8 | Advanced | 2.56% | |
| 9 | New | 2.56% | |
| 10 | Effusion-Synovitis | 2.56% | |
| 11 | Patients | 2.56% | |
| 12 | Osteoarthritis | 2.56% | |
| 13 | Have | 2.56% | |
| 14 | Cisplatin-Ineligible | 2.56% | |
| 15 | (BT8009) | 2.56% | |
| 16 | Nectin-4?targeting | 2.56% | |
| 17 | Pevedotin | 2.56% | |
| 18 | Duravelo-1 | 2.56% | |
| 19 | Metastatic | 2.56% | |
| 20 | Balance | 2.56% | |
| 21 | Effect | 2.56% | |
| 22 | Zelenectide | 2.56% | |
| 23 | Not | 2.56% | |
| 24 | Seen | 2.56% | |
| 25 | Results | 2.56% | |
| 26 | GlucoPure | 2.56% | |
| 27 | Pembrolizumab | 2.56% | |
| 28 | Blood | 2.56% | |
| 29 | Locally | 2.56% | |
| 30 | Untreated | 2.56% | |
| 31 | Previously | 2.56% | |
| 32 | Preliminary | 2.56% | |
| 33 | Pain | 2.56% | |
| 34 | Supplement | 2.56% | |
| 35 | ASCO | 2.56% | |
| 36 | Plant-Based | 2.56% | |
| 37 | Knee | 2.56% | |
| 38 | Phase | 2.56% | |
| 39 | Metabolic | 2.56% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||